Coverage at a glance
| Indication | Coverage |
|---|---|
| Type 2 diabetes | Covered with prior authorization |
Plan type: Commercial non-Medicare. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
This varies by plan. Anthem commercial coverage runs through its pharmacy benefit manager, CarelonRx. Individual employer groups set their own drug benefit, so some plans place tighter limits on GLP-1 drugs or carve them out. Confirm the member's specific plan drug list before assuming coverage.
Coverage by indication
| Step therapy |
What the prior authorization needs:
- Documented diagnosis of type 2 diabetes
- A trial and inadequate response or intolerance to metformin, or a contraindication to metformin, or a history of atherosclerotic cardiovascular disease (ASCVD)
- Prior authorization approved before the pharmacy claim will pay
- Not approved for weight loss. Anthem member benefits generally exclude weight-loss drugs, and Ozempic is FDA-approved for type 2 diabetes only
Policy KYBCBS-CM-025647-23. Source: Network alert: Prescribing glucagon-like peptide-1 (GLP-1) receptor agonists (Anthem Blue Cross and Blue Shield, Commercial). payer_provider_bulletin. Verified August 27, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If the prior-authorization request is denied, the appeal letter library has templates by denial reason, covering peer-to-peer review, Level 1 and Level 2 internal appeal, and external review.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time. Some participants get a placebo, decided at random.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Anthem cover Ozempic?
Anthem commercial plans cover Ozempic for type 2 diabetes, but prior authorization is required. One published Anthem prescribing policy asks for a documented type 2 diabetes diagnosis plus either a trial of metformin (or a contraindication to it) or a history of atherosclerotic cardiovascular disease, though the exact criteria and drug list vary by employer plan. Anthem will not cover Ozempic for weight loss, because its member benefits generally exclude weight-loss drugs and Ozempic is FDA-approved for type 2 diabetes only. Wegovy is the same medicine, semaglutide, at a higher dose approved for weight loss, and it sits under separate weight-loss coverage rules. This reflects the published policy verified August 2026.
What does Anthem require to approve Ozempic?
For type 2 diabetes: true
Why might Anthem deny Ozempic even if I meet the criteria?
Anthem commercial coverage runs through its pharmacy benefit manager, CarelonRx. Individual employer groups set their own drug benefit, so some plans place tighter limits on GLP-1 drugs or carve them out. Confirm the member's specific plan drug list before assuming coverage.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
